Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥5.0-≤10
General Information
Version
8
Revision date
2025-06-09
Product name
ACRIMATE BLANCO
1.2.1 Relevant identified uses
Consumer applications
Manufacturer Name
PPG Industries Panama Inc
Emergency telephone
1-800-441-9695
Icons in SDS
Company Information
company name
PPG Industries Panama Inc
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
Classification of the Not classified substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 16% oral), 34.3% (dermal), 22.4% (inhalation)
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Precautionary statements
General P103 - Read label before use. P102 - Keep out of reach of children. P101 - If medical advice is needed, have product container or label at hand.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Other hazards which do not result in classification
Contains isothiazolinones. May cause allergic reaction. Emits toxic fumes when heated.
Supplemental label elements
Photosensitive agents In case of accidental eye contact, avoid direct exposure to elements (First aid the sun or other sources of UV light as severe irritation including burns may result. measures): These reactions can be delayed – get medical attention if pain, irritation or blistering occurs after contact. In case of accidental skin contact, avoid direct exposure to the sun or other sources of UV light as severe irritation including burns may result. These reactions can be delayed – get medical attention if pain, irritation, rash or blistering occurs after contact. See toxicological information (Section 11)
2.1 Classification of the substance or mixture
Not classified. substance or mixture Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 16% (oral), 34.3% (dermal), 22.4% (inhalation)
